Table 2.
Excess mortality per 100 000 individuals at 100 days | Excess mortality per 100 000 individuals at 300 days | Excess mortality per 100 000 individuals at 400 days after adjusting for vaccination | Excess mortality per 100 000 individuals at 500 days after adjusting for vaccination | |||||||||||||
Explanatory variable | Coefficient | Robust SE | P value | Std. β | Coefficient | Robust SE | P value | Std. β | Coefficient | Robust SE | P value | Std. β | Coefficient | Robust SE | P value | Std. β |
Sociodemographic | ||||||||||||||||
Island status | −50.967 | −11.722 | 0.000 | −0.281 | −49.172 | 11.621 | 0.000 | −0.271 | −76.398 | 22.161 | 0.001 | −0.277 | −120.641 | 24.526 | 0.000 | −0.341 |
Share of pop. >65 years | 335.504 | −120.189 | 0.006 | 0.342 | 339.927 | 121.548 | 0.006 | 0.347 | 447.300 | 209.383 | 0.035 | 0.306 | 518.959 | 278.995 | 0.066 | 0.268 |
Governance and politics | ||||||||||||||||
Corruption Perceptions Index | −1.909 | −0.517 | 0.000 | −0.536 | −1.795 | 0.505 | 0.001 | −0.504 | −2.946 | 0.980 | 0.003 | −0.547 | −3.735 | 1.152 | 0.002 | −0.528 |
Social cohesion | −0.709 | −0.161 | 0.000 | −0.349 | −0.728 | 0.152 | 0.000 | −0.358 | −0.769 | 0.299 | 0.012 | −0.248 | −1.479 | 0.442 | 0.001 | −0.370 |
(6.1) Political and security risk | 1.088 | −0.314 | 0.001 | 0.357 | 0.965 | 0.313 | 0.003 | 0.316 | 1.353 | 0.636 | 0.036 | 0.275 | 2.078 | 0.765 | 0.008 | 0.322 |
Political polarisation* | −6.928 | −4.495 | 0.126 | −0.142 | −7.141 | 4.232 | 0.094 | −0.146 | −8.624 | 7.378 | 0.246 | −0.118 | −10.594 | 8.271 | 0.203 | −0.108 |
Public health capacity | ||||||||||||||||
(2.4) Data integration between human, animal and environmental health sectors | 0.175 | −0.108 | 0.109 | 0.125 | 0.169 | 0.107 | 0.115 | 0.122 | 0.124 | 0.166 | 0.458 | 0.060 | 0.406 | 0.230 | 0.081 | 0.148 |
(1.6) Immunisation | 0.383 | −0.397 | 0.337 | 0.066 | 0.261 | 0.401 | 0.517 | 0.045 | 0.535 | 0.841 | 0.526 | 0.054 | 1.792 | 1.010 | 0.079 | 0.160 |
(4.3) Healthcare access | −0.281 | −0.335 | 0.404 | −0.058 | −0.261 | 0.339 | 0.443 | −0.054 | 0.015 | 0.521 | 0.976 | 0.002 | −0.571 | 0.676 | 0.401 | −0.055 |
Response | ||||||||||||||||
(3.7) Trade and travel restrictions | 0.77 | −0.272 | 0.006 | 0.154 | 0.725 | 0.259 | 0.006 | 0.145 | 1.095 | 0.431 | 0.013 | 0.139 | 0.912 | 0.603 | 0.134 | 0.091 |
Previous experience with SARS or MERS | −24.241 | −10.387 | 0.021 | −0.167 | −24.901 | 10.542 | 0.020 | −0.172 | −29.250 | 20.168 | 0.150 | −0.134 | −14.213 | 24.254 | 0.559 | −0.050 |
(3.2) Exercising response plans | 0.32 | −0.143 | 0.028 | 0.144 | 0.309 | 0.141 | 0.030 | 0.140 | 0.364 | 0.244 | 0.140 | 0.111 | 0.295 | 0.306 | 0.337 | 0.068 |
Stringency of interventions at day X | 0.219 | −0.231 | 0.346 | 0.060 | 0.523 | 0.269 | 0.055 | 0.126 | 0.055 | 0.557 | 0.922 | 0.009 | 0.572 | 0.567 | 0.315 | 0.074 |
Other | ||||||||||||||||
(6.4) Environmental risks | −1.529 | −0.551 | 0.007 | −0.227 | −1.474 | 0.543 | 0.008 | −0.218 | −2.147 | 1.025 | 0.039 | −0.209 | −4.958 | 1.108 | 0.000 | −0.374 |
Polarisation of society* | −10.66 | −4.542 | 0.021 | −0.217 | −9.840 | 4.627 | 0.036 | −0.200 | −14.360 | 8.214 | 0.084 | −0.192 | −11.491 | 11.421 | 0.317 | −0.117 |
(5.3) International commitments | 0.345 | −0.187 | 0.067 | 0.167 | 0.296 | 0.187 | 0.115 | 0.143 | 0.436 | 0.338 | 0.201 | 0.141 | 0.823 | 0.453 | 0.072 | 0.199 |
(5.4) JEE and PVS | −0.345 | −0.237 | 0.148 | −0.106 | −0.296 | 0.235 | 0.211 | −0.091 | −0.399 | 0.424 | 0.349 | −0.082 | −0.170 | 0.536 | 0.752 | −0.028 |
(5.6) Commitment to sharing of genetic and biological data and specimens | −0.65 | −0.611 | 0.290 | −0.088 | 0.557 | 0.584 | 0.343 | −0.075 | −0.372 | 0.922 | 0.687 | −0.036 | −0.762 | 1.086 | 0.484 | −0.054 |
(5.1) IHR reporting compliance and disaster risk reduction | 0.193 | −0.196 | 0.326 | −0.142 | 0.190 | 0.194 | 0.328 | 0.066 | 0.316 | 0.348 | 0.367 | 0.073 | −0.064 | 0.468 | 0.892 | −0.011 |
(2.3) Epidemiology workforce | −0.14 | −0.181 | 0.439 | −0.060 | −0.115 | 0.184 | 0.533 | −0.049 | −0.396 | 0.318 | 0.216 | −0.107 | −0.561 | 0.380 | 0.143 | −0.117 |
Fully vaccinated people per 100 individuals | – | – | – | – | – | – | −0.378 | 0.973 | 0.699 | −0.023 | 0.143 | 0.799 | 0.858 | 0.019 | ||
Constant | 102.88 | 65.894 | 0.121 | 98.572 | 65.871 | 0.137 | 147.662 | 109.237 | 0.180 | 271.6561 | 142.2674 | 0.059 | ||||
Mean variance inflation factor | 1.850 | 1.860 | 1.800 | 1.900 | ||||||||||||
Observations | 128 | 128 | 112 | 117 | ||||||||||||
R-squared | 0.588 | 0.597 | 0.534 | 0.566 | ||||||||||||
Indicates statistical significance to p<0.05 level. | ||||||||||||||||
Indicates statistical significance to p<0.1 level. |
The standardised beta compares the strength of the effect of each individual independent variable to the dependent variable. A negative beta value (represented in green) indicates fewer excess deaths and therefore a better response. A positive beta value (represented in orange) suggests that the variable had a detrimental effect on the quality of the response, correlating with a greater number of deaths. Yellow shading represents a result that is statistically significant to the p<0.05 level. Blue shading represents a result that is statistically significant to the p<0.10 level.
*Variables measuring political and societal polarisation were scored in a manner where a lower score indicates significant polarisation, and an increase in score represents a decrease in polarisation.
JEE, Joint External Evaluation; MERS, Middle East respiratory syndrome; PVS, Performance of Veterinary Services; SARS, Severe acute respiratory syndrome.